Hyunsoo Joshua No, MD, CMD retweetledi
Hyunsoo Joshua No, MD, CMD
768 posts

Hyunsoo Joshua No, MD, CMD
@DoctorNoMD
Radiation Oncology Physician with SCPMG @KaiserRadOncRes | @StanfordRadOnc and @UVMLarnerMed alum | Former Dosimetrist | @TED_ED, @AtTheBeam
Ontario, CA Katılım Nisan 2019
842 Takip Edilen1.1K Takipçiler
Hyunsoo Joshua No, MD, CMD retweetledi

Please welcome David Randall and Shlok Mohanty to the Kaiser Rad/Onc family as our class of 2031. Congratulations and we can't wait for you to be on campus! #match2026 #kaiser @KPSCAL @aboutKP

English
Hyunsoo Joshua No, MD, CMD retweetledi

Cognitive cost or disease control in the management of brain metastases from small cell Lung cancer?-an ongoing debate: 🧠cost vs 🎯?
@ovidiohernando
@rafagar_cia
@MercedesLópez
@raquel_ciervide
pubmed.ncbi.nlm.nih.gov/41521544/

English
Hyunsoo Joshua No, MD, CMD retweetledi

RT with 5 × 5 Gy for Personalized Treatment of Malignant Epidural Compression: Long-Term Results of the PRE-MODE Trial
Congrats and thanks to Prof Rades for counting on me☺️
mdpi.com/2075-4426/15/1…
English
Hyunsoo Joshua No, MD, CMD retweetledi

In honor of Liver Cancer Awareness Month, we’re featuring @melinda_bachini — Chief Patient Officer and cholangiocarcinoma survivor — from the Cholangiocarcinoma Foundation (@curecc)! Hear her inspiring story and discover all that CCF offers patients and families 💚

English
Hyunsoo Joshua No, MD, CMD retweetledi

What is the role of pre-op RT in esophagus/GEJ cancer post ESOPEC & now MATTERHORN?
I think we all agree pre-op RT not needed for all, but here is my take on 5 settings should still consider.
Key is patient selection, weighing risks of local vs. distant recurrence.
@OncoAlert

English
Hyunsoo Joshua No, MD, CMD retweetledi

🫀 “Radio-inmunoterapia, una atractiva combinación.” — La Dra. @raquel_ciervide comparte avances en cáncer de pulmón desde #CardioTox25 💥

Español
Hyunsoo Joshua No, MD, CMD retweetledi

Need a refresher on management of WHO grade 4 #glioma?? 🧠🧠🧠
Check out PGY-3 @cyphotons ARRO case here: astro.org/interest-group…
And the 2025 PRO guidelines here: practicalradonc.org/article/S1879-…
@ARRO_org @ASTRO_org @KPSCALnews

English
Hyunsoo Joshua No, MD, CMD retweetledi
Hyunsoo Joshua No, MD, CMD retweetledi


@AtTheBeam @TrudyWuMD Sitting is the new smoking
English

We always love meeting all the fans at #ASTRO every year! Not hard to find us when Josh insists on walking laps throughout the exhibition hall 😂

English
Hyunsoo Joshua No, MD, CMD retweetledi

#ASTRO25 poster session with our PGY-4 #womenwhocurie with @FaraDayani presenting her work on #peerreview in site-specific H&N #chartrounds and @NancyJZhou discussing #proctitis rates following different #IGRT methods in #prostatecancer
@KPSCalResearch @KPSCALnews


English
Hyunsoo Joshua No, MD, CMD retweetledi
Hyunsoo Joshua No, MD, CMD retweetledi

Understanding the intricate interactions between tumors and the immune system is crucial for developing safe and effective treatments.
Read about this research in an update from the Binkley Lab in our department:
linkedin.com/pulse/explorin…
English
Hyunsoo Joshua No, MD, CMD retweetledi

Caring for patients with cholangiocarcinoma is deeply personal. Thank you @curecc for sharing my story! @UCLAHealth cholangiocarcinoma.org/qa-with-dr-tru…
English
Hyunsoo Joshua No, MD, CMD retweetledi

🔥 Hot off the press: Ralph Weichselbaum, MD, and his team published a new study in @Nature demonstrating that high-dose radiation to primary tumors can unexpectedly promote tumor growth at metastatic sites.
@rweichselbaum @AndrasPiffko @UChicagoRadonc
uchicagomedicine.org/forefront/canc…

English

@joshuapalmermd @TrudyWuMD @AtTheBeam Agreed, but possibly more than that. In 2019, while the match rate was far lower than before, the # of applicants to RO was still close to the # of spots available. I assume most soaped candidates at that time still had heavy RO interest. Certainly dropped the years after.

English

Interesting. @DoctorNoMD and I will be dropping a new @AtTheBeam episode soon to share our experience. Overall, we found the exam to be very fair. Perhaps like most things in life, we ebb and flow
Niema Razavian, MD@RadOncDoc_Niema
The #radonc oral boards results are in: 7️⃣7️⃣% of first time test takers passed - the lowest ⬇️ it’s been in since 2016 Wonder what was different this year 🤔
English
Hyunsoo Joshua No, MD, CMD retweetledi

We thought it important to share some unsolicited thoughts on advice re: personal statements that has been passed down through generations of trainees. Congrats to @mattfarrellmd for once again, sharing his literary talent with us all!
Matthew J. Farrell@mattfarrellmd
@TrudyWuMD, @AnnRaldow_MD, and I wrote a kindly worded letter about residency application personal statements. Our gratitude to all the med students who inspired it! @NEJM @dgsomucla @UCLAHealth nejm.org/doi/full/10.10…
English
Hyunsoo Joshua No, MD, CMD retweetledi

For select breast cancer patients with complete response to neoadjuvant systemic therapy, radiotherapy alone without breast surgery may be feasible, as no tumor recurrences were observed at 5-year follow-up. ja.ma/426mLaK @HenryKuerer HelenMJohnsonMD @SFShaitelmanMD

English











